Serenex
Durham, NC
CEO: Richard Kent
Ticker: NYSE: PFE
Serenex was an oncology-focused drug development company using its novel chemoproteomics technology to accelerate the discovery of high value therapeutics for important human diseases. Serenex was acquired by Pfizer in April 2008.
